David Shaw’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$262K Buy
+1,900
New +$282K ﹤0.01% 4544

Other funds holding PVLA

David Shaw's PVLA Position: Q3 2026 in Review

David Shaw opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 3,647 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #4246 among its holdings. This is a return to the name: David Shaw previously reported a position in PVLA as recently as Q4 2021.

David Shaw first reported a position in PVLA in Q3 2018 and has held it in 12 quarters since. The position peaked at $504K in Q4 2021. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • David Shaw held 3,647 shares of Palvella Therapeutics worth $503K as of Q3 2026.
  • Palvella Therapeutics was a new David Shaw position in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4246 holding.
  • David Shaw first reported a position in Palvella Therapeutics in Q3 2018 and has held it in 12 quarters since.
  • David Shaw's Palvella Therapeutics position peaked at $504K in Q4 2021.
  • 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.